Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) shares were down 3.8% during mid-day trading on Wednesday . The stock traded as low as $0.45 and last traded at $0.45. Approximately 214 shares changed hands during trading, a decline of 88% from the average daily volume of 1,835 shares. The stock had previously closed at $0.47.
Zelira Therapeutics Stock Performance
The business has a 50 day moving average price of $0.49 and a 200-day moving average price of $0.43.
Zelira Therapeutics Company Profile
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Recommended Stories
- Five stocks we like better than Zelira Therapeutics
- What Investors Need to Know About Upcoming IPOs
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Best Stocks Under $5.00
- Williams-Sonoma Stock: Buy It and Never Let It Go
- ETF Screener: Uses and Step-by-Step Guide
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
